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ABSTRACT
BACKGROUND AND PURPOSE: Conventional MR imaging has limitations in detecting focal cortical dysplasia. We assessed the
added value of 7T in patients with histologically proved focal cortical dysplasia to highlight correlations between neuropathology
and ultra-high-field imaging.
MATERIALS AND METHODS: Between 2013 and 2019, we performed a standardized 7T MR imaging protocol in patients with drug-
resistant focal epilepsy. We focused on 12 patients in whom postsurgical histopathology revealed focal cortical dysplasia and
explored the diagnostic yield of preoperative 7T versus 1.5/3T MR imaging and the correlations of imaging findings with histopa-
thology. We also assessed the relationship between epilepsy surgery outcome and the completeness of surgical removal of the
MR imaging–visible structural abnormality.
RESULTS: We observed clear abnormalities in 10/12 patients using 7T versus 9/12 revealed by 1.5/3T MR imaging. In patients with
focal cortical dysplasia I, 7T MR imaging did not disclose morphologic abnormalities (n = 0/2). In patients with focal cortical dyspla-
sia II, 7T uncovered morphologic signs that were not visible on clinical imaging in 1 patient with focal cortical dysplasia IIa (n = 1/4)
and in all those with focal cortical dysplasia IIb (n = 6/6). T2*WI provided the highest added value, disclosing a peculiar intracortical
hypointense band (black line) in 5/6 patients with focal cortical dysplasia IIb. The complete removal of the black line was associ-
ated with good postsurgical outcome (n = 4/5), while its incomplete removal yielded unsatisfactory results (n = 1/5).
CONCLUSIONS: The high sensitivity of 7T T2*-weighted images provides an additional tool in defining potential morphologic
markers of high epileptogenicity within the dysplastic tissue of focal cortical dysplasia IIb and will likely help to more precisely
plan epilepsy surgery and explain surgical failures.
ABBREVIATIONS: EEG 4 electroencephalography; FCD 4 focal cortical dysplasia; SWAN 4 susceptibility-weighted angiography
Focal cortical dysplasia (FCD) is among the most commonstructural brain lesions observed in patients who have under-
gone an operation for drug-resistant epilepsy,1 reaching up to
78% of neuropathologic findings in pediatric series.2,3 The neuro-
pathologic spectrum of FCD includes different cytoarchitectural
subtypes.4
Abnormal cortical layering, affecting either the radial (FCD
type Ia) or tangential organization (FCD type Ib) of the cortex,
characterizes FCD type I. Specific cytologic abnormalities within
a disrupted cortical lamination separate FCD type II, into IIa
(cortical dyslamination þ dysmorphic neurons) and IIb (cortical
dyslamination þ dysmorphic neurons þ balloon cells). In FCD
type III, lamination abnormalities are associated with different
principal brain lesions, namely hippocampal sclerosis (type IIIa),
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tumors (type IIIb), vascular malformations (type IIIc), or any
other principal lesions (FCD type IIId).4
FCD type I is a heterogeneous entity deriving from late postmi-
grational insults to the developing brain, while FCD type II is a
more homogeneous malformation, thought to result from early per-
turbation of cell proliferation and specification.5 Activating brain so-
matic mutations in genes of the mTOR pathway are recognized at
increasing rates in FCD IIa and IIb and hemimegalencephaly.4,6,7
Although type I FCD can, at times, be widespread, involving multi-
ple lobes, neuroimaging may be unrevealing. Otherwise, different
combinations of imaging signs of FCD have been described, includ-
ing blurring of the gray/white matter junction, T2-weighted hyperin-
tensity and T1-weighted hypointensity in the subcortical WM,
regional hypoplasia/atrophy,8,9 and cortical thinning.8,10
MR imaging signs associated with FCD type II include cortical
thickening, increased T2-weighted signal within the cortex or the
underlying WM tapering toward the ventricle (ie, transmantle
sign), blurring of the GM/WM junction, T2-weighted hyperinten-
sity, and T1-weighted hypointensity in the subcortical WM.9,11
However, none of these signs is completely reliable, and the
capability of disclosing regions of cortical dysplasia even at 3T MR
imaging is suboptimal, especially for FCD types I and IIa.9,11-13
In addition, even in patients with MR imaging positive for
structural abnormalities the lesion boundaries often escape
proper recognition, limiting the possibility of performing tailored
surgical resections that reliably include the whole lesion.
Although invasive electroencephalograhic (EEG) recordings help
to identify the seizure-onset zone, histologic abnormalities can
extend beyond the electrographic margin,14 making it problem-
atic to properly define the epileptogenic zone. Poor delimitation
of the lesion by MR imaging represents a major drawback
because completeness of the surgical resection is a key element
for a favorable seizure outcome after the operation.15-20
Improving the detection rate of FCD and reliably identifying the
malformation boundaries are therefore crucial for optimizing
surgical planning.
Ultra-high-field MR imaging offers an enhanced spatial reso-
lution reaching microscopic values due to its high signal-to-noise
ratio, allowing the different components within the cortex to be
visualized, especially through sequences weighted in T2* and
magnetic susceptibility.21-23 The 7T MR imaging has the capabil-
ity of disclosing areas of polymicrogyric cortex in brain regions
previously considered normal using 3T MR imaging24 and of
uncovering cryptic regions of cortical dysplasia in patients with
MR imaging negative for focal epilepsy.25 The 7T MR imaging
has also proved superior to conventional neuroimaging in dis-
closing radiologic signs of FCD.26
We studied 12 patients with FCD using 7T MR imaging and
correlated imaging characteristics with neuropathology findings
and postoperative epilepsy outcome.
MATERIALS AND METHODS
Between 2013 and 2019, we performed a 7T MR imaging proto-
col of investigation with no sedation in patients with drug-resist-
ant focal epilepsy (8 years of age or older).
We performed a retrospective analysis of a suitable surgical
series focusing on 12 of these patients who fulfilled the following
inclusion criteria: 1) clinical and EEG findings suggestive of a
focal, single seizure-onset zone; 2) previous preoperative 1.5/3T
brain MR imaging performed with an optimized protocol for
focal epilepsy, including at least 3D T1-weighted (maximum sec-
tion thickness, 1mm), coronal/axial T2-weighted, and FLAIR
sequences (maximum section thickness, 3mm); 3) high-quality
preoperative 7T brain MR imaging; 4) ablative brain operation
with a histopathologic diagnosis of FCD; and 5) availability of
postsurgical 1.5/3T MR imaging.
We sought to explore the structural characteristics of FCD
using ultra-high-field MR imaging with respect to the specific
histologic subtype and to correlate morphologic data with post-
operative epilepsy outcome, as defined by the Engel criteria.27
The study protocol received approval of the Italian Ministry of
Health and the Pediatric Ethics Committee of the Tuscany
Region. Written informed consent was obtained from all patients
or their representatives.
MR Imaging Acquisitions
All patients had preliminarily undergone diagnostic 1.5/3T
studies with dedicated protocols for focal epilepsy (On-line
Appendix).
We performed the 7T brain MR study at the IMAGO7
Foundation, Pisa, Italy, on a Discovery MR 950 MR imaging
scanner (GE Healthcare; Chicago, Illinois) equipped with a 2-
channel quadrature transmit/32-channel receive head coil
(Model NM008-32-7GE-MR950, Nova Medical, Wilmington,
Massachusetts).
The research study protocol was developed for the investiga-
tion of focal epilepsy and consisted of the following sequences:
3D T1-weighted fast-spoiled gradient recalled or 3D T1-weighted
Silent28 with spatial resolution of 1 1 1 mm3, 3D magnet-
ization-prepared FLAIR sequence29 with spatial resolution of
0.7 0.7 0.7 mm3, 3D susceptibility-weighted angiography
(SWAN) with spatial resolution of 0.328 0.438 1.2 mm3,
targeted 3D-SWAN with spatial resolution of 0.6 0.6 0.6
mm3 used to also produce quantitative susceptibility maps
(On-line Appendix), 2D T2*WI targeted dual echo gradient
recalled echo and 2D T2-weighted FSE, both with in-plane
resolution of 0.313 0.313 mm2 and section thickness of
2 mm, and 2D targeted gray-white matter tissue border
enhancement FSE-inversion recovery30 with in-plane resolu-
tion of 0.5 0.5 mm2 and section thickness of 2mm. We chose
the localization of targeted sequences according to the seizure-
onset zone, as defined by clinical and EEG findings.
Postsurgical brain MRIs were obtained either on the 1.5T
(ACS-NT and Achieva) or 3T (Achieva; Philips Healthcare, Best,
the Netherlands) MR imaging systems, with minimum sequence
requirements of 3D T1-weighted (maximum section thickness,
1mm), coronal/axial T2-weighted, and FLAIR sequences (maxi-
mum section thickness, 3 mm).
Brain MR Imaging Analysis and Interpretation
One experienced neuroradiologist and 1 neurologist with exper-
tise in advanced neuroimaging, blinded to the histopathologic
diagnosis and to the epilepsy outcome, evaluated both the preop-
erative 1.5/3T and 7T examinations for signs of FCD (increased
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cortical thickness, cortical thinning, abnormal sulcation, regional
hypoplasia/atrophy, transmantle sign, blurring of the GM/WM
junction, T2-weighted hyperintensity, and T1-weighted hypo-
intensity in subcortical WM). The analysis was performed
in a joint session on a dedicated workstation (Advantage
Workstation 4.6; GE Healthcare).
To optimize assessment of the extent of surgical resection, we
aligned images of the postsurgery clinical MR imaging with those
acquired with the 7T system using the FMRIB Linear Image
Registration Tool (FLIRT; http://www.fmrib.ox.ac.uk/fsl/fslwiki/
FLIRT).31
Surgical Procedure and Histopathologic Assessment
We planned the surgical resections on the basis of the epilepto-
genic zone, as defined according to each patient’s clinical, imag-
ing, and EEG characteristics.
The histopathologic review of resected brain tissue was per-
formed at Children’s Hospital Anna Meyer, Florence, and at the
Istituto Neurologico Carlo Besta, Milan, by 3 experienced neuro-
pathologists (On-line Appendix). Histopathologic interpretation
was based on the international league against epilepsy (ILAE)
classification of focal cortical dysplasia.4 To explore the histopa-
thologic counterpart of the radiologically defined black line (see
below), we relied on macroscopic anatomic landmarks on the
surgical specimen, limited to patients who had stereo-EEG
recordings (patients 3 and 7), on electrode traces.
RESULTS
Demographic and clinical information of the study population
is shown in the On-line Table. Neuropathologic assessment
revealed FCD Ib in 2 patients (patients 5 and 6), FCD IIa in 4
(patients 4, 8, 9, and 12), and FCD IIb in 6 (patients 1–3, 7, 10,
and 11).
Preoperative 1.5/3T MR imaging revealed abnormal findings
in 9/12 (75%) patients. In detail, in the 2 patients with FCD Ib,
1.5/3T MR imaging was unrevealing; in the 4 patients with FCD
IIa, there was blurring of the GM/WM junction, which was asso-
ciated with lobar hypoplasia, abnormal gyral contouring, and, in
1 patient, increased cortical thickness. Patients with FCD IIb had
either unrevealing 1.5/3T MR imaging findings (Patient 10) or
exhibited variably combined signs of FCD, namely abnormal sul-
cal/gyral contouring (patients 2, 3, 7, and 11), increased cortical
thickness (patients 3, 7, and 11), increased T2-weighted intracort-
ical signal (patients 1, 3, and 7), blurring of the GM/WM junction
(patients 1–3 and 11), a T2-weighted hyperintense transmantle
sign (patients 1–3, 7, and 11), T2-weighted hyperintensity in the
subcortical WM (patients 1–3, 7, and 11), and T1-weighted hypo-
intensity in the subcortical WM (patients 2, 3, 7, and 11).
The 7T MR imaging examination demonstrated clear mor-
phologic or signal abnormalities in 10/12 (83%) patients. In both
patients with FCD Ib, we considered 7T MR imaging to be unre-
vealing, though we observed a nonspecific granular and blurry
appearance of the subcortical WM, which was not visible on pre-
vious examinations (On-line Fig 1). In all 10 patients with FCD
II, the 7T MR imaging examination confirmed the 1.5/3T find-
ings but revealed additional subtle signs in one of the patients
with FCD IIa (patient 12) and in all those with FCD IIb (patients
1–3, 7, 10, and 11). The elevated spatial resolution allowed a bet-
ter visualization of the abnormal gyral contouring in all patients
with FCD IIb and in 1 with FCD IIa (patient 12), resolving the
anatomic details of a single gyrus, which yielded an apparent
increased cortical thickness on conventional imaging due to par-
tial volume effects.
The transmantle sign and the WM signal alterations were
clearly defined due to the high 7T SNR in 5/5 patients with such
radiologic features. Susceptibility-weighted images revealed an
abnormal venous drainage undisclosed by conventional angio-
MR venography in 1 patient (patient 2) and depicted a peculiar
intracortical hypointense band (black line) with high susceptibil-
ity on quantitative susceptibility maps in 5/6 patients with FCD
IIb (patients 1–3, 7, and 10, whose 1.5/3T T2*-weighted images
were unrevealing) (Figs 1 and 2).
Postsurgical histopathology demonstrated widespread dys-
morphic neurons and balloon cells over the cortical regions hav-
ing such a T2*WI hypointense band (black line) (patients 1–3, 7,
and 10) (On-line Fig 2). On the contrary, dysmorphic neurons
and balloon cells spared the cerebral cortex and were atypically
limited to subcortical WM in the single patient with FCD IIb
who did not exhibit the T2*WI hypointense black line on 7T
imaging (patient 11).
Postsurgical outcome was unsatisfactory in both patients with
FCD Ib (patients 5 and 6), while it was favorable in 8/10 (80%) of
those with FCD II (Engel class I, patients 1–4, 8–10 and 12). In
patients with FCD IIb, by analyzing the coregistration between
the 7T examination and the postsurgical MR imaging, we could
assess whether the surgical procedure had completely removed
the WM/GM blurring (n = 3/4), the transmantle sign (n = 0/4),
the subcortical T2-weighted hyperintense region (n = 1/3),
and the intracortical black line (n = 4/5) (On-line Table 2).
We found that incomplete removal of subcortical regions corre-
sponding to the transmantle sign (patients 1–3) or to T2-weighted
hyperintensity (patient 1) did not hamper a favorable epilepsy out-
come (ie, Engel class I). Conversely, cortical resections with either
incomplete removal of the underlying area of GM/WM blurring
seen in FCD IIa (n=1/4, patient 8) or of the intracortical T2*WI
black line typical of FCD IIb (n=1/5, patient 7) yielded an unfavor-
able postsurgical outcome (ie, Engel classes II–IV). In patients 3
and 7, we also acquired postoperative 7T scans. In patient 7, who
still experienced drug-resistant seizures during follow-up, a residual
intracortical hypointense black line persisted next to the surgical
crater in the SWAN images of the postoperative 7T scan (Fig 1).
Conversely, the black line had completely disappeared in patient 3,
who was seizure-free after the operation (Fig 2).
DISCUSSION
In our series of 12 surgically treated patients with histologically
proved FCD, 7T MR imaging acquisition yielded positive results
in 10 of them, identifying FCD type II in 10/10 exhibiting this
histopathologic subtype. From a neuroimaging perspective, the
capability of conventional MR imaging to detect signs of cortical
dysplasia has been demonstrated to be suboptimal because about
half of patients with FCD type I,9 10% of those with type IIb,32
and up to 49% of those with type IIa11 are reported to exhibit
nonspecific MR imaging findings.
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As observed in previous studies,25,26 7T may uncover structural
abnormalities that are not apparent using conventional imaging.
However, in this series, the diagnostic gain was confined to
FCD type II, while only minor features could be identified with
hindsight in FCD type I (On-line Fig 1).
Ultra-high field imaging revealed with higher resolution the MR
imaging signs previously observed by 1.5/3T exams and also
detected additional subtle findings in FCD IIb. In particular, we
identified a new imaging marker of FCD IIb, consisting of an intra-
cortical band of hypointense signal, visible using SWAN sequences,
which we termed “black line,” located in the deep layers beneath
seemingly preserved upper cortical layers. We first observed this
intracortical signal change in a patient (included here as patient 10)
with FCD type IIb, belonging to a clinical series of focal epilepsies
studied at 7T,25 and have now confirmed it in all patients with
pathologically proved type IIb FCD (patients 1–3, 7, and 10), except
patient 11, who atypically exhibited balloon cells and dysmorphic
neurons only in the subcortical WM but not within the cortex.
In a study matching ex vivo 7T imaging with histopathology,
T2-weighted imaging disclosed an inhomogeneous intracortical
signal intensity in the core of FCD IIb lesions, corresponding to
disorganized myelinated fibers and numerous clustered dysmor-
phic neurons and balloon cells.33 In view of the similarities our in
vivo images have with these ex vivo findings, it is possible that
the clustering of abnormal cells and disorganized intracortical
fibers of type IIb FCD represent the pathologic substrate of the
intracortical black line layer.
Overall, T2*WI signal decreases with reduced fiber and neu-
ronal cell density, as reported in both the normal and dysplastic
cerebral cortex of FCD type I and IIa.34,35 FCD type IIb features
hypomyelination and neuronal rarefaction,36 yet the contribution
of intracortical dysmorphic neurons and balloon cells in generat-
ing the in vivo T2*WI signal is still unclear. T2*WI signal inten-
sity might also be modulated by the amount of intracortical iron,
but clear evidence of increased microglia35 or abnormal iron con-
centration is still lacking.34 Quantitative histopathology would be
essential for a comprehensive understanding of the relationship
between tissue microstructure and MR imaging signal changes in
FCD subtypes.37 From a clinical perspective, although our series
is too small to draw firm conclusions, we are inclined to consider
the black line as sensitive and specific for FCD II since we never
observed it in association with other subtypes of dysplasia and in
healthy controls (published in part in Cosottini et al38).
About 80% of patients with FCD IIb also exhibited the trans-
mantle sign, which both conventional and ultra-high-field imag-
ing clearly revealed. This sign is more frequently observed in type
IIb FCD11 and reflects a reduction of myelinated fibers, with high
density of balloon cells and reduced oligodendrocytes with
abnormal nuclei.36 Defective myelination is likely the conse-
quence of an exuberant balloon cell proliferation in early prolifer-
ation corticogenesis, likewise observed in tuberous sclerosis
complex.39 In 5/6 patients with FCD IIb, 7T imaging also
revealed signal changes in the subcortical white matter. In 4 of
these patients, all exhibiting both white matter hyperintensity
and the intracortical black line (4/6 patients with FCD IIb),
T2*WI bears a resemblance to the flaglike appearance described
by Colon et al26 using 7T in FCD. In a single patient, we also
uncovered a venous drainage abnormality (patient 2), which may
sometimes be located next to the dysplastic cortex in malforma-
tions of cortical development.40
To quantify the completeness of surgical excision and corre-
late it with clinical outcome in patients with FCD IIb, we
FIG 1. A 7T brain imaging of patient 7 (FCD IIb) with unsatisfactory postoperative outcome (Engel class III). A 7T preoperative FLAIR (A), magni-
fied preoperative (B) and postoperative (C) coronal gradient recalled-echo images, postoperative coronal FLAIR (D), preoperative axial SWAN
image (E), magnified preoperative (F) and postoperative (G) axial SWAN images, and postoperative axial FLAIR (H). Before the operation, FLAIR
images show the transmantle sign, while T2*WI reveals an intracortical hypointense layer (black line) (white arrows in B and F). Postoperative
T2*WI highlights the persistence of the intracortical hypointense layer black line, next to the postsurgical crater (white arrows in C and G).
Postoperative FLAIR images (D and H) show that the transmantle sign and the white matter hyperintensity were not surgically removed.
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compared the preoperative and postoperative MR imaging. For
this purpose, we coregistered ultra-high-field SWAN imaging
with preoperative high-resolution anatomic T1-weighted
images. Coregistration with postoperative anatomic T1-
weighted images was then obtained to establish the relation-
ship between the spatial coordinates of FCD and the postsur-
gical crater. Rigid coregistration of pre- and postoperative
images did not guarantee an optimal comparison in 2/6
patients (patients 2 and 3) because the postresection brain
was largely distorted. To obviate this limitation, we used ana-
tomic landmarks to visually assess removed-versus-spared
FCD tissue.
We found that in patients with FCD IIb, clinical outcome cor-
related with the complete removal of the intracortical black line
because its complete excision was accompanied by the best post-
surgery outcomes (patients 1–3, 10, and 11), while the only
patient with incomplete removal still experienced disabling seiz-
ures during follow-up (patient 7).
Persistence of the transmantle sign after the operation did
not hamper a good seizure outcome (patients 1, 2, and 3),
confirming that the demyelinated white matter underlying
the dysplastic cortex is not necessarily and directly related to
epileptogenesis.41
CONCLUSIONS
We compared conventional brain
MR imaging studies performed with
different magnet strengths with a
standardized 7T MR imaging proto-
col of investigation. In particular, half
of the patients had undergone a pre-
liminary 1.5T scan optimized for epi-
lepsy, and one-fourth of the patients
did not have T2*WI included in con-
ventional MR imaging studies. These
limitations hamper a head-to-head
comparison with ultra-high-field im-
aging and limit the generalization
of our findings, which should be con-
sidered preliminary and exploratory.
In addition, we could not focus
on a point-by-point correspondence
between macroscopic imaging char-
acteristics and histologic findings.
Such a drawback could be partially
overcome by also studying ex vivo 7T
scans of the surgical specimen and
including only patients studied by
stereo-EEG to use the electrode
tracks as landmarks, but technical
limitations in coregistration between
presurgical and postsurgical brain
images are still to be solved.
Preoperative investigations of FCD
combine electroclinical data, MR
imaging, and, in selected patients,
[18F] FDG-PET and invasive elec-
trophysiologic monitoring.42 The
sensitivity of SWAN images at ultra-high-field strengths in
detecting the intracortical component of FCD IIb, which we
designated as the black line, represents a potential adjunctive
tool for characterizing the epileptogenic dysplastic cortex and
defining its extent, thereby improving surgical planning and
prognostication, and weighting the indications for a re-opera-
tion in case of failure. A study specifically addressing the pres-
ence of the black line sign on standardized 3T MR imaging
would provide further information on the clinical value of
such findings in clinical practice.
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